References
- Booth N A. The natural inhibitors of fibrinolysis. Haemostasis and Thrombosis, A L Bloom, C D Forbes, D P Thomas, E G.D Tuddenham. Churchill Livingstone, Edinburgh 1994; 699–717
- Estellès A, Gilabert J, Aznar J, Loskutoff D J, Schleef R R. Changes in the plasma levels of type 1 and type 2 plasminogen activator inhibitors in normal pregnancy and in patients with severe preeclampsia. Blood 1989; 74: 1332–8
- Reith A, Booth N A, Moore N R, Chriuckshank D J, Bennett B. Plasminogen activator inhibitors (PAI‐1 and PAI‐2) in the normal pregnancies, preeclampsia and hydatidi‐form mole. Br J Obstet Gynecol 1993; 100: 370–4
- Kruithof E K O, Tran‐Thang C, Gudingchet A, Hauert J, Nicoloso G, Genton C, Welti H, Bachmann F. Fibrinolysis in pregnancy: a study of plasminogen activator inhibitors. Blood 1987; 69: 460–6
- de Boer K, Lecander I, ten‐Cate J W, Borm J J J, Treffers P E. Placental‐type plasminogen activator inhibitor in preeclampsia. Am J Obstet Gynecol 1988; 158: 518–22
- Persson P H, Weldner B M. Normal range growth curves for fetal biparitial diameter, occipito frontal diameter, mean abdominal diameters and femur length. Acta Obstet Gynecol Scand 1986; 65: 759–61
- Persson P H, Weldner B M. Intra‐uterine weight curves obtained by ultrasound. Acta Obstet Gynecol Scand 1986; 65: 169–73
- Montan S, Olofsson P, Solum T. Classification of the nonstress test and fetal outcome in 1056 pregnancies. Acta Obstet Gynecol Scand 1985; 64: 639–44
- Åstedt B. The placenta and haemostatic balance. The Human Placenta: A Guide for Clinicians and Scientists, C W.G Redman, I L Sargent, P M Starkey. Blackwell Scientific, Oxford 1993; 291–309
- Feinberg R F, Kao L C, Haimowitz J E, Queenan J T, Wun T C, Strauss J F, Kliman H J. Plasminogen activator inhibitor types 1 and type 2 in human trophoblasts; PAI‐1 is an immunocytochemical marker of invading trophoblasts. Lab Invest 1989; 61: 20–6
- Estellés A, Gilabert J, Keeton M, Eguchi Y, Aznar J, Grancha S, Espana F, Loskutoff D, Schleef R R. Altered expression of plasminogen activator type 1 in placentas from pregnant women with preeclampsia and/or intruterine fetal growth retardation. Blood 1994; 84: 143–50
- Åstedt B, Hagerstrand I, Lecander I. Cellular localisation in placenta of placental type plasminogen activator inhibitor. Thromb Haemostas 1986; 56: 63–5
- Estellés A, Gilabert J, Espana F, Aznar J, Galbis M. Fibrinolytic parameters in normotensive pregnancy with intrauterine fetal growth retardation and in severe preeclampsia. Am J Obstet Gynecol 1991; 165: 138–42
- Estelles A, Gilabert J, Grancha S, Espana F, Chirivella M, Aznar J, Loskutoff D. Expression of fibrinolytic components in plasmas and placentas from patients with trophoblastic disease. Fibrinolysis 1994; 8(suppl 1)149, abstr 422
- Bagshawe K D, Lawler S D. Hydatidiform mole and choriocarcinoma. Obstetrics, S A Turnull, G Chamberlain. Churchill Livingstone, London 1989; 259–66
- Eston C W. Gestational trophoblastic disease. Obstetrical and Gynaecological Pathology, H Fox. Churchill Livingstone, London 1987; 1045–78
- Fox H. The placenta in pregnancy hypertension. Hypertension in Pregnancy, P C Rubin. Elsevier, Amsterdam 1988; 16–37
- Redam C W G. Hypertension in pregnancy. Obstetrics, S A Turbull, G Chamberlain. Churchill Livingstone, London 1989; 515–41